Our Advantages
Experience
  • 46%,phase I
  • 29%,phase III
  • 24%,phase II
  • 1%,phase IV
  • 49%,tumor
  • 8%,infection
  • 15%,autoimmunity
  • 4%,ophthalmology
  • 12%,metabolism
  • 2%,pain
  • 10%,breathing